A detailed history of West End Advisors, LLC transactions in Baxter International Inc stock. As of the latest transaction made, West End Advisors, LLC holds 6 shares of BAX stock, worth $216. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 6 -0.0%
Holding current value
$216
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$32.87 - $43.55 $65 - $87
-2 Reduced 25.0%
6 $0
Q4 2023

Jan 18, 2024

BUY
$31.71 - $38.95 $31 - $38
1 Added 14.29%
8 $0
Q3 2023

Oct 19, 2023

BUY
$37.32 - $49.29 $261 - $345
7 New
7 $0
Q2 2022

Jul 28, 2022

BUY
$63.83 - $80.0 $63 - $80
1 Added 20.0%
6 $385,000
Q1 2022

Apr 26, 2022

BUY
$76.85 - $89.45 $76 - $89
1 Added 25.0%
5 $387,000
Q2 2021

Jul 15, 2021

BUY
$80.5 - $88.01 $322 - $352
4 New
4 $322,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.2B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track West End Advisors, LLC Portfolio

Follow West End Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.